- Home
- ALLR vs GENK Comparison
ALLR vs GENK Comparison
Compare ALLR & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- GENK
- Stock Information
- Founded
- ALLR 2004
- GENK 2011
- Country
- ALLR United States
- GENK United States
- Employees
- ALLR N/A
- GENK N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- ALLR Health Care
- GENK Consumer Discretionary
- Exchange
- ALLR Nasdaq
- GENK Nasdaq
- Market Cap
- ALLR 15.8M
- GENK 16.3M
- IPO Year
- ALLR N/A
- GENK 2023
- Fundamental
- Price
- ALLR $1.66
- GENK $3.21
- Analyst Decision
- ALLR Strong Buy
- GENK Strong Buy
- Analyst Count
- ALLR 1
- GENK 2
- Target Price
- ALLR $9.00
- GENK $7.00
- AVG Volume (30 Days)
- ALLR 21.5M
- GENK 44.1K
- Earning Date
- ALLR 08-15-2025
- GENK 11-11-2025
- Dividend Yield
- ALLR N/A
- GENK 3.77%
- EPS Growth
- ALLR N/A
- GENK N/A
- EPS
- ALLR N/A
- GENK N/A
- Revenue
- ALLR N/A
- GENK $216,137,000.00
- Revenue This Year
- ALLR N/A
- GENK $12.35
- Revenue Next Year
- ALLR N/A
- GENK $14.62
- P/E Ratio
- ALLR N/A
- GENK N/A
- Revenue Growth
- ALLR N/A
- GENK 10.67
- 52 Week Low
- ALLR $0.61
- GENK $3.10
- 52 Week High
- ALLR $3.91
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- ALLR 59.12
- GENK 42.98
- Support Level
- ALLR $1.78
- GENK $3.11
- Resistance Level
- ALLR $1.92
- GENK $3.39
- Average True Range (ATR)
- ALLR 0.25
- GENK 0.15
- MACD
- ALLR 0.02
- GENK 0.02
- Stochastic Oscillator
- ALLR 52.25
- GENK 32.35
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.